Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Return on Assets: 2017-2018

Historic Return on Assets for Astria Therapeutics (ATXS) over the last 1 years, with Dec 2018 value amounting to -0.62%.

  • Astria Therapeutics' Return on Assets rose 71.00% to -0.62% in Q4 2018 from the same period last year, while for Dec 2018 it was -0.62%, marking a year-over-year increase of 71.00%. This contributed to the annual value of -0.91% for FY2018, which is N/A change from last year.
  • According to the latest figures from Q4 2018, Astria Therapeutics' Return on Assets is -0.62%, which was down 15.56% from -0.54% recorded in Q3 2018.
  • In the past 5 years, Astria Therapeutics' Return on Assets registered a high of -0.54% during Q3 2018, and its lowest value of -1.50% during Q1 2018.
  • For the 2-year period, Astria Therapeutics' Return on Assets averaged around -0.95%, with its median value being -0.78% (2018).
  • Data for Astria Therapeutics' Return on Assets shows a peak YoY skyrocketed of 71bps (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Astria Therapeutics' Return on Assets stood at -1.33% in 2017, then soared by 71bps to -0.62% in 2018.
  • Its last three reported values are -0.62% in Q4 2018, -0.54% for Q3 2018, and -0.78% during Q2 2018.